This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chinese Academy of Medical Sciences. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Inventor Xin Zhen
Introduction
Xin Zhen is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating various diseases. His work is recognized for its potential impact on cardiovascular and cerebrovascular health.
Latest Patents
Xin Zhen holds a patent for an indolo[2',3′:3,4]pyrido[2,1-b]quinazoline compound. This compound is represented by a general formula and has multiple applications. It can be used in the manufacture of a medicament for treating cardiovascular and cerebrovascular diseases. Additionally, it is formulated to increase the expression of AMPK, ABCA1, and SR-BI. The compound also activates nuclear receptors while inhibiting the activity of NLRP3, IL-1β, NF-κB, and MAPKs. Furthermore, it promotes cellular cholesterol efflux and serves as a medicament for anti-inflammation.
Career Highlights
Xin Zhen is affiliated with the Chinese Academy of Medical Sciences, where he conducts his research and development. His work has led to advancements in the understanding and treatment of various health conditions. He has been recognized for his innovative approaches and dedication to improving medical outcomes.
Collaborations
Xin Zhen collaborates with several esteemed colleagues, including Shuyi Si and Yanni Xu. Their combined expertise enhances the research efforts at the Chinese Academy of Medical Sciences.
Conclusion
Xin Zhen's contributions to medicinal chemistry and his innovative patent highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile